2017 AHA / ACC Update on 2014 Valvular Disease Q7

Asymptomatic Severe Primary MR

According to the
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease Failure” p 262

“Mitral valve surgery is recommended for asymptomatic patients with chronic severe primary MR and LV dysfunction (_________ and/or left ventricular end-systolic diameter [LVESD] >/=40 mm, stage C2)”

a) LVEF <30%
b) LVEF <45%
c) LVEF 30% to 45%
d) LVEF 30% to 60%

click here for answer

(D)

“Mitral valve surgery is recommended for asymptomatic patients with chronic severe primary MR and LV dysfunction (LVEF 30% to 60% and/or left ventricular end-systolic diameter [LVESD] >/=40 mm, stage C2) (76–82).”

Leave Comment

Your email address will not be published. Required fields are marked *